Document is current
Any future updates will be listed below
-
Authors
Xiao, Zhehao
Luo, Ling
Weng, Weipin
Yu, Erhan
Zheng, Jiahao
Pan, Xiaodong
Wang, Yanping
Wang, Rui
-
Funding
Funding for this research was provided by:
Fujian Provincial Health Technology Project (Grant No. 2021CXA050)
Joint Funds for the innovation of science and Technology, Fujian province (Grant No. 2021Y9074)
Technology and Innovation Foundation of Fujian, China (Grant No. 2021Y0021)
the Fujian Provincial Key Clinical Specialty Construction Project (Official document No. 884 [2022)
the Natural Science Foundation of Fujian Province, China (Grant No. 2022J01798)
the Research Foundation for Advanced Talents of Fujian Medical University (Grant No. XRCZX2022009)
the Fujian Provincial Natural Science Foundation of China (Grant No. 2022J01720)
- License Information
-
More Information
Article History
Received: 11 August 2025
Accepted: 27 September 2025
First Online: 4 November 2025
Declarations
:
: The UK Biobank study was approved by the North West Multi-centre Research Ethics Committee of the National Health Service in the United Kingdom. Written informed consent was obtained from all participants. This analysis was conducted under UK Biobank approval number 470494.
: Not applicable.
: The authors declare no competing interests.
